Back to Search Start Over

Evaluation of Ophthalmic Oxymetazoline as an Adjunct Treatment for Acquired Blepharoptosis Due to Periocular Synkinesis.

Source :
Clinical Trials Week; 7/31/2023, p642-642, 1p
Publication Year :
2023

Abstract

In the treatment of blepharoptosis, oxymetazoline acts on the superior tarsal muscle, Muller's muscle, to elevate the eyelid. In the treatment of blepharoptosis, oxymetazoline acts on the superior tarsal muscle, Muller's muscle, to elevate the eyelid. [Extracted from the article]

Details

Language :
English
ISSN :
15436772
Database :
Complementary Index
Journal :
Clinical Trials Week
Publication Type :
Periodical
Accession number :
167380062